Par Pharmaceutical Companies

Pharma

Prior to acquisition, Par Pharmaceutical had approximately 1,500-2,000 employees.

Overview

Par Pharmaceutical, Inc., a subsidiary of Endo International plc, is a specialty pharmaceutical company that develops, manufactures, and markets a broad portfolio of generic and branded pharmaceuticals. Par specializes in niche segments of the pharmaceutical market, focusing on developing and marketing difficult-to-formulate and high-barrier-to-entry products. Their product portfolio includes a range of dosage forms and delivery systems, including injectables, oral solids, and controlled-release products. The company has a significant presence in both the U.S. and international markets.

Vision

Before being acquired, Par Pharmaceutical's vision was to be a leading specialty pharmaceutical company, recognized for its commitment to quality, innovation, and customer service.

Mission

Before being acquired, Par Pharmaceutical's mission was to provide high-quality, affordable medicines to patients and customers.

Headquarters

Indore

Specialties & Industries

Generic PharmaceuticalsBranded Pharmaceuticals (prior to acquisition)Women's Health (prior to acquisition)Urology (prior to acquisition)Specialty PharmaceuticalsPharmaceutical ManufacturingPharmaceutical DevelopmentPharmaceutical ManufacturingHealthcareGeneric PharmaceuticalsProduct Based CompanyManufacturing & Industrial Automation

Open Positions

No open positions at the moment

Check back later for new opportunities